Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM

• Váldodahkkit: N. S. Kostritca (Dahkki), R. M. Rabinovich (Dahkki), R. M. Shakhnovich (Dahkki), I. S. Yavelov (Dahkki), R. G. Gulyan (Dahkki), Yu. K. Rytova (Dahkki), S. N. Tereschenko (Dahkki), A. D. Erlikh (Dahkki), D. V. Pevzner (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Столичная издательская компания, 2024-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Aim. To analyze the frequency, indications, and outcomes of using glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction (AMI) in Russia based on data from a multicenter registry.Material and methods. This work is part of the REGION-MI (Russian Registry of Acute Myocardial Inf...